Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient.

Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F.

Genome Biol. 2014 Nov 7;15(11):490. doi: 10.1186/s13059-014-0490-3.

PMID:
25418686
[PubMed - in process]
Free PMC Article
2.

Multidrug-resistant tuberculosis treatment with linezolid-containing regimen.

Farshidpour M, Ebrahimi G, Mirsaeidi M.

Int J Mycobacteriol. 2013 Dec 1;2(4):233-236.

PMID:
25110635
[PubMed]
Free PMC Article
3.

WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis.

Chang KC, Yew WW, Tam CM, Leung CC.

Antimicrob Agents Chemother. 2013 Sep;57(9):4097-104. doi: 10.1128/AAC.00120-13. Epub 2013 Jun 17. Review.

PMID:
23774431
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Rising to the challenge: new therapies for tuberculosis.

Wong EB, Cohen KA, Bishai WR.

Trends Microbiol. 2013 Sep;21(9):493-501. doi: 10.1016/j.tim.2013.05.002. Epub 2013 Jun 11. Review.

PMID:
23764389
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Linezolid for treatment of chronic extensively drug-resistant tuberculosis.

Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE 3rd.

N Engl J Med. 2012 Oct 18;367(16):1508-18. doi: 10.1056/NEJMoa1201964.

PMID:
23075177
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Exploring prospects of novel drugs for tuberculosis.

Janssen S, Jayachandran R, Khathi L, Zinsstag J, Grobusch MP, Pieters J.

Drug Des Devel Ther. 2012;6:217-24. doi: 10.2147/DDDT.S34006. Epub 2012 Sep 7. Review.

PMID:
22973091
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.

Sacksteder KA, Protopopova M, Barry CE 3rd, Andries K, Nacy CA.

Future Microbiol. 2012 Jul;7(7):823-37. doi: 10.2217/fmb.12.56. Review.

PMID:
22827305
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?

Dooley KE, Obuku EA, Durakovic N, Belitsky V, Mitnick C, Nuermberger EL; Efficacy Subgroup, RESIST-TB.

J Infect Dis. 2013 May 1;207(9):1352-8. doi: 10.1093/infdis/jis460. Epub 2012 Jul 17. Review.

PMID:
22807518
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

New drugs to treat tuberculosis.

Swindells S.

F1000 Med Rep. 2012;4:12. doi: 10.3410/M4-12. Epub 2012 Jun 1.

PMID:
22719795
[PubMed]
Free PMC Article
10.

Antimycobacterial Activities of Novel 5-(1H-1,2,3-Triazolyl)Methyl Oxazolidinones.

Phillips OA, Udo EE, Varghese R.

Tuberc Res Treat. 2012;2012:289136. doi: 10.1155/2012/289136. Epub 2012 Apr 11.

PMID:
22577542
[PubMed]
Free PMC Article
11.

rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains.

Beckert P, Hillemann D, Kohl TA, Kalinowski J, Richter E, Niemann S, Feuerriegel S.

Antimicrob Agents Chemother. 2012 May;56(5):2743-5. doi: 10.1128/AAC.06227-11. Epub 2012 Feb 27.

PMID:
22371899
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk